Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
The disease hobbles families and economies.
Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.
COPD receives low attention as a women’s health issue. It’s time to change that.
Novartis is developing an experimental drug for weight loss.
Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.
The molecule restores the activity of neurons and neural circuits in a model of the disease.
Novartis works tirelessly with third-party organizations to improve access to cancer care.
Suzan Akello describes what life has been like since her cancer diagnosis.
Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.
New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.
Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.